Goldan Keith A. - Insider Non-Derivative Transactions at Syndax Pharmaceuticals Inc (SNDX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 14, 2024, Goldan Keith A.'s relationship to Syndax Pharmaceuticals Inc (SNDX) is Officer (Chief Financial Officer), and currently has 52,623 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SNDX insiders.
Data Source: SEC.
Goldan Keith A. - Insider Non-Derivative Transactions of SNDX Common Stock
Goldan Keith A. - Insider Non-Derivative Transactions at SNDX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 15, 2024 | P -- (Common Stock) | 1250 | 20.03 | 52623 |
| Feb 8, 2024 | Acquisition -- (Common Stock) | 35000 | 0 | 39673 |
| Feb 8, 2024 | Acquisition -- (Common Stock) | 11700 | 0 | 51373 |
| Feb 1, 2024 | J -- (Common Stock) | 1183 | 17.42 | 4673 |
| Aug 1, 2023 | J -- (Common Stock) | 862 | 18.12 | 3490 |
| Jun 14, 2023 | Sell -- (Common Stock) | 577 | 22.31 | 2628 |